These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 6553606)

  • 41. An initial assessment of augmentin for the treatment of paediatric infections in general practice.
    Jeffries MG; Rose AJ; Williams HN
    Br J Clin Pract; 1983 Feb; 37(2):61-6. PubMed ID: 6860540
    [No Abstract]   [Full Text] [Related]  

  • 42. [Use of rovamycin and amox-clav in patients with infectious-inflammatory pathology of the ORL organs].
    Kriukov AI; Poliakova TS; Ogorodnikov DS; Gaĭvoronskaia GA
    Vestn Otorinolaringol; 1996; (2):42-5. PubMed ID: 8711846
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparative in vitro activity of augmentin against community and hospital-acquired gram-negative bacteria.
    Glupczynski Y; McGillavry G; Yourassowsky E
    Acta Clin Belg; 1988; 43(2):109-14. PubMed ID: 3400375
    [No Abstract]   [Full Text] [Related]  

  • 44. Amoxicillin-potassium clavulanate: rational pharmacology meets clinical infectious disease.
    Reed MD; Blumer JL
    Clin Pharm; 1984; 3(6):653-4. PubMed ID: 6509880
    [No Abstract]   [Full Text] [Related]  

  • 45. A clinical and bacteriological evaluation of Augmentin: a new broad spectrum antibiotic in general practice.
    Hansrod D; Howalder R; Rozar GJ
    East Afr Med J; 1983 Nov; 60(11):778-82. PubMed ID: 6368188
    [No Abstract]   [Full Text] [Related]  

  • 46. [A combination of amoxycillin with clavulanic acid (Augmentin) in various types of urinary tract infections caused by microbes producing beta-lactamase].
    Prát V; Horcicková M; Hatala M; Liska M; Matousovic K
    Cas Lek Cesk; 1985 Jun; 124(23):711-4. PubMed ID: 3874692
    [No Abstract]   [Full Text] [Related]  

  • 47. [Clarithromycin versus amoxicillin-clavulanic acid in the treatment of acute maxillary sinusitis in adults].
    Géhanno P; Barry B; Chauvin JP; Hazebroucq J
    Pathol Biol (Paris); 1996 Apr; 44(4):293-7. PubMed ID: 8763594
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Amoxicillin-clavulanate (Clavulin). Infectious Diseases and Immunization Committee, Canadian Paediatric Society.
    Infectious Diseases and Immunization Committee
    CMAJ; 1985 Oct; 133(8):739. PubMed ID: 4042055
    [No Abstract]   [Full Text] [Related]  

  • 49. Comparative efficacy and safety of oral fleroxacin and amoxicillin/clavulanate potassium in skin and soft tissue infections.
    Tassler H
    Am J Med; 1993 Mar; 94(3A):159S-165S. PubMed ID: 8452174
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Combination antibiotic for resistant bacterial strains.
    Pepper GA
    Nurse Pract; 1985 Mar; 10(3):49-50. PubMed ID: 3845395
    [No Abstract]   [Full Text] [Related]  

  • 51. [Pediatric suspensions of amoxicillin and clavulanic acid in the treatment of bacterial infections of otorhinolaryngologic importance and the upper respiratory tract].
    Amendola F; Natuzzi M; De Mattia D; Schettini F
    Minerva Pediatr; 1989 Feb; 41(2):97-103. PubMed ID: 2786988
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Once-a-day therapy for sinusitis: a comparison study of cefixime and amoxicillin.
    Edelstein DR; Avner SE; Chow JM; Duerksen RL; Johnson J; Ronis M; Rybak LP; Bierman WC; Matthews BL; Kohlbrenner VM
    Laryngoscope; 1993 Jan; 103(1 Pt 1):33-41. PubMed ID: 8421417
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Treatment of skin and skin structure infections: a comparative study of Augmentin and cefaclor.
    Parish LC; Aten EM
    Cutis; 1984 Dec; 34(6):567-70. PubMed ID: 6394217
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Susceptibilities of 540 anaerobic gram-negative bacilli to amoxicillin, amoxicillin-BRL 42715, amoxicillin-clavulanate, temafloxacin, and clindamycin.
    Appelbaum PC; Spangler SK; Shiman R; Jacobs MR
    Antimicrob Agents Chemother; 1992 May; 36(5):1140-3. PubMed ID: 1324639
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Clinical study on amoxicillin in otorhinolaryngological field (author's transl)].
    Hommura Y; Sakamoto Y; Matsukawa J; Shinkawa A
    Jpn J Antibiot; 1975 Jun; 28(3):353-62. PubMed ID: 1152288
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Intravenous Augmentin in bacteraemia and severe invasive polymicrobial sepsis.
    Mehtar S; Ball AP
    J Antimicrob Chemother; 1985 Jun; 15(6):765-71. PubMed ID: 4030538
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Beta-lactamase inhibitors].
    Gialdroni Grassi G
    G Ital Chemioter; 1982; 29(1):1-10. PubMed ID: 6764431
    [No Abstract]   [Full Text] [Related]  

  • 58. Clavulanate-potentiated amoxycillin: activity in vitro and bioavailability in the dog.
    Bywater RJ; Palmer GH; Buswell JF; Stanton A
    Vet Rec; 1985 Jan; 116(2):33-6. PubMed ID: 3871985
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficacy of BRL 25000 against Serratia marcescens, Enterobacter cloacae, and Citrobacter freundii in urinary tract infections.
    Nakazawa H; Hashimoto T; Nishiura T; Mitsuhashi S
    Antimicrob Agents Chemother; 1983 Sep; 24(3):437-9. PubMed ID: 6357078
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Augmentin therapy in the treatment of urinary tract infections in general practice.
    Abbas AM; Goel PK; Venkit N; Gowers E
    Br J Clin Pract; 1984 Feb; 38(2):49-51. PubMed ID: 6704296
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.